Roberto Padovani

Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.

M. Culler, M. Zatelli, D. Piccin, 2003, The Journal of clinical endocrinology and metabolism.

Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin a secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro.

A. Bottoni, M. Culler, L. Cavazzini, 2004, The Journal of clinical endocrinology and metabolism.